When President-elect Donald Trump landed at the Green Bay Austin Straubel International Airport back in October, he used a ...
We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are ...
Zepbound, as expected, was more effective in promoting weight loss. Eli Lilly's Zepbound drug holds potential to dominate the global obesity market due to its superior efficacy and strategic ...
Enter Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the makers behind blockbuster glucagon-like peptide-1 (GLP-1) agonists such as Mounjaro, Zepbound, Ozempic, and Wegovy -- all of which are ...
The latest data shows stability, even signs of growth, returning to the for-hire trucking segment. Canada’s spot market was flat in November, but the truck-to-load ratio improved for carriers. ACT ...
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...
Eli Lilly announced FDA approval of Zepbound as the first prescription medicine for adults with moderate-to-severe obstructive sleep apnea. In addition, adults on Zepbound lost an average of 45 ...
Eli Lilly sells one of the most sought-after types of drugs today: weight loss drugs. The company’s Zepbound and Mounjaro have brought in blockbuster revenue, and more growth could be on the ...
Sleep apnea, a sleep disorder typically managed with a medical device that aids in breathing, now has its first FDA-approved drug therapy, an Eli Lilly medicine initially developed as a treatment ...
FedEx is the latest to jump on the bandwagon. The US logistics group plans to split out its higher margin freight trucking division into a separate publicly listed company. While the move should ...
And it was an interesting year from a heavy-truck perspective. The North American trucking industry is still slogging along toward the Phase 3 Greenhouse Gas Emissions regulations set to wallop us ...